KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Dec 06, 2021 $6.60 $6.60 $5.44 $5.73 1 125 382
Dec 03, 2021 $6.94 $6.97 $6.61 $6.61 828 299
Dec 02, 2021 $6.67 $6.91 $6.62 $6.90 876 142
Dec 01, 2021 $6.70 $6.88 $6.64 $6.70 1 168 250
Nov 30, 2021 $6.52 $6.89 $6.42 $6.61 2 274 572
Nov 29, 2021 $6.74 $6.79 $6.49 $6.52 1 002 692
Nov 26, 2021 $6.95 $6.96 $6.74 $6.75 829 123
Nov 24, 2021 $7.15 $7.15 $6.94 $7.04 615 446
Nov 23, 2021 $7.26 $7.29 $7.02 $7.21 1 255 933
Nov 22, 2021 $7.33 $7.46 $7.17 $7.31 756 395
Nov 19, 2021 $7.13 $7.35 $7.10 $7.34 783 448
Nov 18, 2021 $7.30 $7.34 $7.01 $7.22 1 147 328
Nov 17, 2021 $7.35 $7.53 $7.26 $7.37 896 423
Nov 16, 2021 $7.20 $7.46 $7.06 $7.39 835 275
Nov 15, 2021 $7.16 $7.41 $7.10 $7.26 953 729
Nov 12, 2021 $7.04 $7.04 $6.80 $7.02 793 254
Nov 11, 2021 $7.05 $7.09 $6.90 $7.01 903 408
Nov 10, 2021 $6.97 $7.12 $6.89 $7.08 1 156 403
Nov 09, 2021 $6.96 $7.14 $6.82 $7.00 1 117 413
Nov 08, 2021 $6.51 $7.01 $6.25 $6.97 1 025 189
Nov 05, 2021 $5.93 $6.64 $5.93 $6.60 875 958
Nov 04, 2021 $6.09 $6.19 $5.95 $5.98 1 028 909
Nov 03, 2021 $5.93 $6.12 $5.87 $6.10 563 813
Nov 02, 2021 $5.66 $5.92 $5.58 $5.91 464 261
Nov 01, 2021 $5.94 $6.00 $5.57 $5.68 874 334
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT